Epidemiology of ALS in Italy: A 10-year prospective population-based study

Neurology

Volumn 72, Issue 8, 2009, Pages 725-731

  Chio A ^a,e   Mora, G ^b   Calvo, A ^a   Mazzini, L ^c   Bottacchi, E ^d   Mutani, R ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Scientific Institute of Pavia   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d Ospedale Regionale di Aosta   (Italy)

^e Department of Neuroscience ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; AGE DISTRIBUTION; COHORT ANALYSIS; MIDDLE AGED; PROSPECTIVE STUDY; SEX RATIO;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; SEX DISTRIBUTION; YOUNG ADULT;

EID: 62349138647     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000343008.26874.d1     Document Type: Article

References (24)

1. Chiò A, Traynor BJ, Lombardo F, et al. Prevalence of SOD1 mutations in the Italian ALS population. Neurology 2008;70:533-537.
2. McGuire V, Longstreth WT Jr, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology 1996;47:571-573.
3. Piemonte and Valle dAosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology 2001;56:239-244.
4. Logroscino G, Beghi E, Zoccolella S, et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population-based study. J Neurol Neurosurg Psychiatry 2005;76:1094-1098.
5. Forbes RB, Colville S, Parratt J, Swingler RJ. The incidence of motor neuron disease in Scotland. J Neurol 2007; 254:866-869.
6. O'Toole O, Traynor BJ, Brennan P, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry 2007;79:30-32.
7. Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G, for the SLALOM Group. Incidence of ALS in Lombardy, Italy. Neurology 2007;68:141-145.
8. Seljeseth YM, Vollset SE, Tysnes OB. Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology 2000;55:1262-1266.
9. Noonan CW, White MC, Thurman D, Wong LY. Temporal and geographic variation in United States motor neuron disease mortality, 1969 to 1998. Neurology 2005; 64:1215-1221.
10. Sejvar JJ, Holman RC, Bresee JS, Kochanek KD, Schonberger LB. Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology 2005; 25:144-152.
11. Messina R, ed. Sanità in Cifre. Calderini: Ozzano dell'Emilia (BO); 2006.
12. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.
13. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis: Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial Clinical Limits of Amyotrophic Lateral Sclerosis workshop contributors. J Neurol Sci 1994;124(suppl):96-107.
14. Schoemberg BS. Calculating confidence intervals for rates and ratios. Neuroepidemiology 1983;2:257-265.
15. Hook E, Regal R. Capture recapture methods in epidemiology: methods and limitations. Epidemiol Rev 1995; 17: 243-264.
16. Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology 2002;59:280-282.
17. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Amyotrophic lateral sclerosis mimic syndromes: a population-based study. Arch Neurol 2000;57:109-113.
18. Davenport RJ, Swingler RJ, Chancellor AM, et al. Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry 1996;60:147-151.
19. Forbes RB, Colville S, Swingler RJ. Scottish ALS/MND Register: the epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over. Age Ageing 2004; 33:131-134.
20. Qiu C, De Ronchi D, Fratiglioni L. The epidemiology of the dementias: an update. Curr Opin Psychiatry 2007;20: 380-385.
21. Twelves D, Perkins KS, Counsell C. Systematic review of incidence studies of Parkinson's disease. Mov Disord 2003;18:19-31.
22. Johnston CA, Stanton BA, Turner MR, et al. Amyotrophic lateral sclerosis in an urban setting: a population-based study of inner city London. J Neurol 2006;253: 1642-1643.
23. Logroscino G, Traynor BJ, Hardiman O, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 2008;79:6-11.
24. Beghi E, Mennini T, Bendotti C, et al. The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure. Curr Med Chem 2007;14:3185-3200.